Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.730
+0.020 (1.17%)
At close: Aug 13, 2025, 4:00 PM
1.730
0.00 (0.00%)
After-hours: Aug 13, 2025, 5:31 PM EDT
Immuron Market Cap
Immuron has a market cap or net worth of $11.87 million as of August 13, 2025. Its market cap has decreased by -14.58% in one year.
Market Cap
11.87M
Enterprise Value
6.92M
1-Year Change
-14.58%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $11.87M, a decrease of -57.75%. That is a compound annual growth rate of -10.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 9.70M | - |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |